Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
November 2023
EMJ Oncology 11 [Supplement 5] 2023
Incidence and mortality rates of endometrial cancer, the most common gynaecological cancer in high-income countries, are increasing…
10
Mins
8 Nov 2023
Disparities in the Incidence and Outcome of Endometrial Cancer: Interviews with Two Key Opinion Leaders
Endometrial cancer is one of the most common gynaecological cancers in high-income countries, and often presents with comorbidities…
6
Mins
8 Nov 2023
Interview: John Marshall
You have to remember that I am a very old oncologist. So, when I first started, there was almost nothing in the world of GI cancer. I was…
8 Nov 2023
Advancements in NSCLC: In Pursuit of a Life for Every Patient
Tune in to our latest podcast for valuable insights on non-small cell lung cancer (NSCLC). Esteemed contributors to this discussion include…
8 Nov 2023
Does Testosterone Replacement Improve Steatotic Liver Disease?
Male hypogonadism is associated with visceral obesity and metabolic syndrome. The present study aims to compare the effects of testosterone treatment with a placebo in treating non-alcoholic fatty liver disease in older hypogonadal males.
Changing the tide on health inequities
Listen to Marion Brooks, Vice President and US Country Head, Diversity, Equality and Inclusion, Novartis discussing diversity, equity and inclusion.
7 Nov 2023
Novel Scoring Tool Predicts Alcoholic Relapse Following Liver Transplant
New data suggests that the risk of alcoholic relapse in patients with alcohol-related liver disease who underwent liver transplant may be more accurately determined with the help of a new scoring system.
Protecting the informed patient from misinformation
Read about the role the pharma industry can play in ensuring patients can access the right information about medical conditions and medicines.
6 Nov 2023
Longer Prostatic Urethra Increases Risk of Adverse Events Following Radiation Therapy
Detected on MRI, increased prostatic urethral length has been shown to increase risk of adverse events following radiation therapy for prostate cancer. Read more.
6 Nov 2023
Improved Survival from Radical Prostatectomy in Patients with High-Risk Localised Prostate Cancer
An observational study from the University of California, San Francisco, USA discovered that one option for treating high-risk localised prostate cancer showing favourable survival outcomes is radical prostatectomy.
←
1
2
3
…
367
368
369
370
371
372
373
…
1,130
1,131
1,132
→
We’ve noticed you’re accessing
from
North/South America.
View
View